S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 4,001 to 4,020 of 7,427

Issue Date	Title / Author(s) / Citation	File
2022-01	Ocular Motor Findings Aid in Differentiation of Spinocerebellar Ataxia Type 17 from Huntingtons Disease Lee, Sun-Uk; Kim, Ji-Soo; Yoo, Dallah; Kim, Aryun; Kim, Hyo-Jung; Choi, Jeong-Yoon; Park, Ji-Yun; Jeong, Seong-Hae; Kim, Jong-Min; Park, Kun-Woo Cerebellum	DOI
2022-06	Odontoid Incidence: A Novel Cervical Parameter Influencing Cervical Alignment From Top to Bottom Lee, Jae-Koo; Hyun, Seung-Jae; Kim, Ki-Jeong Neurospine, Vol.19 No.2, pp.463-471	DOI
2021	Off-target Binding of Glu-Ureido-Lys-Targeted Radioligands to PSMA-like Alternative Proteins : A Potential Therapeutic Target in PSMA-negative and Neuroendocrine Prostate Carcinoma 모하마드레자	view file link
2020-09	Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study Domchek, Susan M.; Postel-Vinay, Sophie; Im, Seock-Ah; Park, Yeon Hee; Delord, Jean-Pierre; Italiano, Antoine; Alexandre, Jerome; You, Benoit; Bastian, Sara; Krebs, Matthew G.; Wang, Ding; Waqar, Saiama N.; Lanasa, Mark; Rhee, Joon; Gao, Haiyan; Rocher-Ros, Vidalba; Jones, Emma, V; Gulati, Sakshi; Coenen-Stass, Anna; Kozarewa, Iwanka; Lai, Zhongwu; Angell, Helen K.; Opincar, Laura; Herbolsheimer, Pia; Kaufman, Bella The Lancet Oncology, Vol.21 No.9, pp.1155-1164	DOI
2023-08	Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial Senkus, Elzbieta; Delaloge, Suzette; Domchek, Susan M.; Conte, Pierfranco; Im, Seock-Ah; Xu, Binghe; Armstrong, Anne; Masuda, Norikazu; Fielding, Anitra; Robson, Mark; Tung, Nadine International Journal of Cancer, Vol.153 No.4, pp.1-12	DOI
2017-08	Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Robson, Mark; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Li, Wei; Tung, Nadine; Armstrong, Anne; Wu, Wenting; Goessl, Carsten; Runswick, Sarah; Conte, Pierfranco New England Journal of Medicine, Vol.377 No.6, pp.523-533	DOI
2017-12	Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu The Lancet Oncology, Vol.18 No.12, pp.1637-1651	DOI
2020-05	Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis Im, Seock-Ah; Xu, Binghe; Li, Wei; Robson, Mark; Ouyang, Quchang; Yeh, Dah-Cherng; Iwata, Hiroji; Park, Yeon Hee; Sohn, Joo Hyuk; Tseng, Ling-Ming; Goessl, Carsten; Wu, Wenting; Masuda, Norikazu Scientific Reports, Vol.10 No.1, p. 8753	DOI
2024	Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study Drew, Yvette; Kim, Jae-Weon; Penson, Richard T.; O'Malley, David M.; Parkinson, Christine; Roxburgh, Patricia; Plummer, Ruth; Im, Seock-Ah; Imbimbo, Martina; Ferguson, Michelle; Rosengarten, Ora; Steeghs, Neeltje; Kim, Min Hwan; Gal-Yam, Einav; Tsoref, Daliah; Kim, Jae-Hoon; You, Benoit; De Jonge, Maja; Lalisang, Roy; Gort, Eelke; Bastian, Sara; Meyer, Kassondra; Feeney, Laura; Baker, Nigel; Ah-See, Mei-Lin; Domchek, Susan M.; Banerjee, Susana Clinical cancer research : an official journal of the American Association for Cancer Research, Vol.30 No.1, pp.50-62	DOI
1971-06	Oleanolic Acid 유도체의 소염작용에 관한 연구 김현우 Seoul J Med, Vol.12 No.2, pp. 109-115	view file
2013-07	Oligonol Inhibits Dextran Sulfate Sodium-Induced Colitis and Colonic Adenoma Formation in Mice Yum, Hye-Won; Zhong, Xiancai; Park, Jin; Na, Hye-Kyung; Kim, Nayoung; Lee, Hye Seung; Surh, Young-Joon Antioxidants and Redox Signaling, Vol.19 No.2, pp.102-114	DOI
1987-06	Olivopontocerebellar Atrophy In an Infant (an Autopsy Case) Hwang, Juck Joon; Lee, Yoon Seong; Lee, Jung Bin; Chi, Je G. Seoul J Med, Vol.28 No.2, pp. 149-153	view file
2021-05	Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study Park, Keunchil; Janne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Kang, Jin-Hyoung; Lee, Dae Ho; Cho, Byoung Chul; Yu, Chong-Jen; Pang, Yong Kek; Felip, Enriqueta; Kim, Hyunjin; Baek, Eunhye; Noh, Young Su Cancer, Vol.127 No.9, pp.1407-1416	DOI
2023-05	OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician?s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Robson, Mark E.; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Tung, Nadine; Armstrong, Anne; Dymond, Mike; Fielding, Anitra; Allen, Allison; Conte, Pierfranco European Journal of Cancer, Vol.184, pp.39-47	DOI
2019-04	OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Robson, M. E.; Tung, N.; Conte, P.; Im, S. -A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Domchek, S. M. Annals of Oncology, Vol.30 No.4, pp.558-566	DOI
2022	Oncogenesis of central neurocytoma 탐린	view file link
2018-02	Oncogenic potential of germline mutations in lysosomal storage disease-associated genes 신정훈	view file
2016-02	Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer Chung, Soo Young; Jung, Yoon Yang; Park, In Ae; Kim, Hyojin; Chung, Yul Ri; Kim, Ji Young; Park, Soo Young; Im, Seock-Ah; Lee, Kyung-Hun; Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik; Lee, Chul; Kim, Tae-Yong; Ryu, Han Suk Clinical and Experimental Metastasis, Vol.33 No.2, pp.179-185	DOI
2022-09	Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis Jung, Hye-Sol; Kim, Hyeong Seok; Kang, Jae Seung; Kang, Yoon Hyung; Sohn, Hee Ju; Byun, Yoonhyeong; Han, Youngmin; Yun, Won-Gun; Cho, Young Jae; Lee, Mirang; Kwon, Wooil; Jang, Jin-Young Cancers, Vol.14 No.18, p. 4360	DOI
2019-02	Oncologic catastrophe of unintended non-radical management after chemoradiotherapy for mid or low rectal cancer: a multicentre comparative study with intended non-radical management 송광섭	view file

1 200 201 202 203 204 205 206 372